Keywords
post-COVID syndrome, endothelial dysfunction, hypersympathicotonia, cyticoline, meldonium, ethylmethylhydroxylpyridine succinate.
How to Cite
Cherska, M., Kucharchuk, K., & Haiiova, O. (2021). Options for corrections of the post-COVID syndrome in routine clinical practice. The Practitioner, (1), 18-23. Retrieved from https://plr.com.ua/index.php/journal/article/view/612
Abstract
The present review article gives the results of source analysis regarding recommendations to detect, diagnose and treat the patients having post-COVID syndrome. NICE (the National Institute for Clinical Excellence, 2020) Guideline defines post-COVID syndrome as features and symptoms which develop either during or after infection corresponding to COVID‑19. The products influencing endothelium and CNS play an important role in treating post-COVID syndrome. The following products of the company Nikopharm are available in the Ukrainian market: Nikomex (ethylmethylhydroxylpyridine succinate), Mildrocard (meldonium) and Pharmaxon (cyticoline); their clinical characteristics may help in routine clinical practice in order to ease the post-COVID syndrome caused by increased activity of the sympathetic nervous system and endothelial dysfunction: fatigue, tachycardia, asthenia, cognitive and psycho-emotional disorders, insomnia etc.
References
1. Chen Y. Emergingcoronaviruses: Genomestructure, replication, andpathogenesis // J. Med. Virol. — 2020. — Vol. 92. — P. 418-423.
2. World Health Organisation. WHO Response in Countries [Електронний ресурс]. — Режим доступу: https://www.who.int/emergencies/diseases/
novel-coronavirus‑2019/donate/who-response-in-countries. Accessed 4. — May, 2020.
3. Aghagoli G., Gallo Marin B., Soliman L.B., Sellke F.W. Cardiac involvement in COVID‑19 patients: Risk factors, predictors, and complications: A review // J. Card. Surg. — 2020, Jun. — Vol. 35 (6). — P. 1302-1305. doi: 10.1111/jocs.14538. Режим доступу: https://doi.org/10.1111/jocs.14538
4. Кобилянський Ю.Ю. Особенности патогенеза коронавирусной инфекции и перспективные направления терапии [Електронний ресурс]. — Режим доступу: https://health-ua.com/article/60327-osobennosti-patogeneza-koronavirusnoj-infektcii-iperspektivnye-napravleniya
5. Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID‑19 // Am. J. Emerg. Med. — 2020. — Vol. 38 (7). — P. 1504-1507. doi:10.1016/j.ajem.2020.04.048https://bestpractice.bmj.com/topics/en-gb/3000201.
6. NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) have today (30 October 2020) given more details about the forthcoming guideline on post-COVID syndrome. [Електронний ресурс]. — Режим доступу: https://www.nice.org.
uk/news/article/nice-sign-and-rcgp-set-out-further-details-about-the-uk-guideline-on-management-of-the-long-term-effects-of-covid‑19
7. Post-COVID Syndrome: What Should You Do If You Have Lingering COVID‑19 Symptoms? [Електронний ресурс]. — Режим доступу: https://
www.houstonmethodist.org/blog/articles/2020/nov/post-covid-syndrome-what-should-you-do-if-you-have-lingering-covid‑19-symptoms/
8. NICE, SIGN and RCGP set out further details about the UK guideline on management of the long-term effects of COVID‑19. [Електронний ресурс]. — Режим доступу: https://www.nice.org.uk/news/article/nice-sign-and-rcgp-set-out-further-details-about-the-uk-guideline-on-management-ofthe-
long-term-effects-of-covid‑19
9. South A.M., Diz D.I., Chappell M.C. COVID‑19, ACE2, and the cardiovascularc onsequences // Am. J. Physiol. Heart Circ. Physiol. Published. — 2020. — Vol. 318, No 5. [Електронний ресурс]. — Режим доступу: https://doi.org/10.1152/ajpheart.00217.2020
10. Корекція ендотеліальної дисфункції при ішемічній хворобі серця в поєднанні з цукровим діабетом / Н.В. Снігир [та ін.] // Ліки України. — 2016, № 3. — С. 53-56.
11. Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. et al. Neurologic manifestations of hospitalized patients with coronavirus disease. — 2019 in Wuhan, China // JAMA, Neurology. — 2020.
12. Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C. et al. Neurologic features in severe SARS-CoV-2 infection // N. Engl. J. Med. — 2020. — Vol. 382. — P. 2268-2270. doi: 10.1056/NEJMc2008597.
13. Марценковський І.А., Марценковська І.І., Здорик І.Ф. Проблеми охорони психічного здоров’я, зумовлені пандемією COVID‑19. [Електронний ресурс]. — Режим доступу: https://health-ua.com/article/60141-problemi-ohoroni-psihchnogo-zdorovya — zumovlen-pandemyu-COVID19
14. Desforges M., LeCoupanec A., Brison É., Meessen-Pinard M., Talbot P.J. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans // In Infectious Diseasesand Nano medicine I. — 2014. — Р. 75-96. Режим доступу: https://health-ua.com/
article/60141-problemi-ohoroni-psihchnogo-zdorovya — zumovlen-pandemyu-COVID19
15. Valtorta N.K., Kanaan M., Gilbody S., Ronzi S., Hanratty B. Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies // Heart. — 2016. — Vol. 102 (13). — Р. 1009-1016.
2. World Health Organisation. WHO Response in Countries [Електронний ресурс]. — Режим доступу: https://www.who.int/emergencies/diseases/
novel-coronavirus‑2019/donate/who-response-in-countries. Accessed 4. — May, 2020.
3. Aghagoli G., Gallo Marin B., Soliman L.B., Sellke F.W. Cardiac involvement in COVID‑19 patients: Risk factors, predictors, and complications: A review // J. Card. Surg. — 2020, Jun. — Vol. 35 (6). — P. 1302-1305. doi: 10.1111/jocs.14538. Режим доступу: https://doi.org/10.1111/jocs.14538
4. Кобилянський Ю.Ю. Особенности патогенеза коронавирусной инфекции и перспективные направления терапии [Електронний ресурс]. — Режим доступу: https://health-ua.com/article/60327-osobennosti-patogeneza-koronavirusnoj-infektcii-iperspektivnye-napravleniya
5. Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID‑19 // Am. J. Emerg. Med. — 2020. — Vol. 38 (7). — P. 1504-1507. doi:10.1016/j.ajem.2020.04.048https://bestpractice.bmj.com/topics/en-gb/3000201.
6. NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) have today (30 October 2020) given more details about the forthcoming guideline on post-COVID syndrome. [Електронний ресурс]. — Режим доступу: https://www.nice.org.
uk/news/article/nice-sign-and-rcgp-set-out-further-details-about-the-uk-guideline-on-management-of-the-long-term-effects-of-covid‑19
7. Post-COVID Syndrome: What Should You Do If You Have Lingering COVID‑19 Symptoms? [Електронний ресурс]. — Режим доступу: https://
www.houstonmethodist.org/blog/articles/2020/nov/post-covid-syndrome-what-should-you-do-if-you-have-lingering-covid‑19-symptoms/
8. NICE, SIGN and RCGP set out further details about the UK guideline on management of the long-term effects of COVID‑19. [Електронний ресурс]. — Режим доступу: https://www.nice.org.uk/news/article/nice-sign-and-rcgp-set-out-further-details-about-the-uk-guideline-on-management-ofthe-
long-term-effects-of-covid‑19
9. South A.M., Diz D.I., Chappell M.C. COVID‑19, ACE2, and the cardiovascularc onsequences // Am. J. Physiol. Heart Circ. Physiol. Published. — 2020. — Vol. 318, No 5. [Електронний ресурс]. — Режим доступу: https://doi.org/10.1152/ajpheart.00217.2020
10. Корекція ендотеліальної дисфункції при ішемічній хворобі серця в поєднанні з цукровим діабетом / Н.В. Снігир [та ін.] // Ліки України. — 2016, № 3. — С. 53-56.
11. Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. et al. Neurologic manifestations of hospitalized patients with coronavirus disease. — 2019 in Wuhan, China // JAMA, Neurology. — 2020.
12. Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C. et al. Neurologic features in severe SARS-CoV-2 infection // N. Engl. J. Med. — 2020. — Vol. 382. — P. 2268-2270. doi: 10.1056/NEJMc2008597.
13. Марценковський І.А., Марценковська І.І., Здорик І.Ф. Проблеми охорони психічного здоров’я, зумовлені пандемією COVID‑19. [Електронний ресурс]. — Режим доступу: https://health-ua.com/article/60141-problemi-ohoroni-psihchnogo-zdorovya — zumovlen-pandemyu-COVID19
14. Desforges M., LeCoupanec A., Brison É., Meessen-Pinard M., Talbot P.J. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans // In Infectious Diseasesand Nano medicine I. — 2014. — Р. 75-96. Режим доступу: https://health-ua.com/
article/60141-problemi-ohoroni-psihchnogo-zdorovya — zumovlen-pandemyu-COVID19
15. Valtorta N.K., Kanaan M., Gilbody S., Ronzi S., Hanratty B. Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies // Heart. — 2016. — Vol. 102 (13). — Р. 1009-1016.
Downloads
Download data is not yet available.